
Fears of global aluminium shortages that could affect the production of clean energy technologies intensified after Iran struck two major Gulf aluminium producers, sending prices to a four-year high. The Middle East accounts for 9% of the world’s production of aluminum, which is essential to a wide range of industries from transportation, construction, and packaging, as well as the manufacture of solar panels, electrical transmission systems, wind turbines, and EVs.
Export shipments to the US and Europe had already come to a halt because of the effective closure of the Strait of Hormuz, and Morgan Stanley economists singled out aluminium as carrying a high level of risk across the value chain. Andy Farida, an aluminium analyst at Fastmarkets, told Semafor that high prices would be passed on to end-users, ultimately causing demand destruction. “A prolonged shutdown (with little to no alternative supplies other than Russia and China) could cripple the supply of aluminium to support the production of clean and green technology,” he said, adding that relief could come “if governments allow some sanctioned Russian and Chinese aluminium to be imported.”
LATEST POSTS
- 1
Top Breakfast Food: What's Your Morning Enjoyment? - 2
Flight cancellations: Full list of 40 airports hit by FAA cuts amid government shutdown - 3
Story of ‘first Black Briton’ rewritten by advances in ancient DNA technology - 4
ISS astronaut snaps stunning nighttime photo of Florida and Cuba | Space photo of the day for Dec. 29, 2025 - 5
Building Tough Connections: Individual Bits of knowledge on Association
Artemis II crew cleared to depart Earth orbit, head for moon
Moon rush: These private spacecraft will attempt lunar landings in 2026
Former 'Bachelorette' welcomes 1st baby via emergency c-section
Alice Wong, founder of the Disability Visibility Project, dies at 51
Egypt's cafés and shops forced to close early due to Iran war
A volcanic eruption may have catalyzed the plague's arrival in Europe, study suggests
Flourishing in Retirement: Individual Accounts of Post-Profession Satisfaction
Ads promising cosmetic surgery patients a ‘dream body’ with minimal risk get little scrutiny
Bayer reports positive results for blood thinner after 2023 setback













